Coriell Life Sciences Research Finds Precision Medicine Has Reached a Global Tipping Point for Adoption


Big news coming from Coriell Life Sciences. Their newly published research, authored by leaders at the company, reveals that the time is finally right for healthcare systems, employers, and governments to establish genome-informed clinical decision-making as the new standard of care.

“The stage is set for leaders around the world to change healthcare as we know it,” says co-author Scott Megill, President and CEO of Coriell Life Sciences. “Studies have shown that using genetic information to provide more targeted therapeutic care significantly improves patient outcomes and reduces the overall cost of healthcare. This is especially true for pharmacogenomics (PGx), which uses an individual’s DNA to determine if medications are likely to be unsafe or ineffective for them specifically. We’re now entering a new age where barriers have transformed into boons for PGx-enabled precision medicine.”

The research paper, published by Cambridge University Press, examines the maturation of critical factors required for the use of clinical genetics at scale, including:

  • Clinical utility
  • Laboratory technology
  • User acceptance
  • Implementation models
  • Economic value

Coriell Life Sciences is headquartered in the Navy Yard is a precision medicine genetics company using genetic science and research to improve lives, reduce healthcare costs, and simplify decision-making for their customers throughout the United States and around the world.

You can read the full story on the Coriell Life Sciences website.


Axalta innovation featured image

Axalta Wins Globally Distinguished Innovation Award

Axalta, whose 175,000 square-foot Global Innovation Center is located at the Navy Yard, recently won a major globally distinguished award for innovation. The Business Intelligence Group presented Axalta with the 2023 BIG Innovation Award for its AquaEC® Flex Broad Bake Electrocoat product.

The BIG Innovation Awards recognize organizations and people who bring new ideas to life. Whether that idea is big or small, these ideas change the way we experience the world.

Axalta’s AquaEC® Flex, helps enable mass production of electric vehicles by providing extreme corrosion protection for batteries and complex vehicle designs.

“Axalta is proud to receive this award that further demonstrates our ongoing product innovation and performance,” said Robert Roop, Axalta’s Chief Technology Officer. “We are constantly innovating for our customers. The increased demand for electric vehicles drove the need for a more sustainable e-coat that applies with uniform thickness over complex vehicle designs while maintaining manufacturing productivity. Our innovation ensures that critical parts that carry and protect battery packs are heat-cured with the rest of the body frame, enabling automakers to co-produce electric vehicles and internal combustion vehicles on the same manufacturing line.”

Read the full press release on Axalta’s website.

Axalta innovation award